What is BSX stock price today?

BSX (Boston Scientific Corp) stock is trading at $44.62 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is BSX stock going up or down today?

BSX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy BSX stock now?

The decision to buy BSX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is BSX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for BSX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is BSX stock overvalued or undervalued?

BSX currently trades at a P/E ratio of 20.21 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if BSX is fairly priced.

What is BSX's P/E ratio?

BSX has a price-to-earnings (P/E) ratio of 20.21, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is BSX's market cap?

BSX (Boston Scientific Corp) has a market capitalization of $71.81 billion, making it a mid-cap stock.

What is BSX's price to book ratio?

Price-to-book ratio for BSX is available on our dashboard along with other valuation metrics.

Does BSX pay dividends?

BSX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is BSX's dividend yield?

BSX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is BSX stock a good long-term investment?

BSX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is BSX's revenue growth rate?

Revenue growth data for BSX is available on our dashboard with detailed financial statement analysis.

Profitability metrics for BSX are available on our dashboard with complete income statement analysis.

What are the risks of investing in BSX?

Key risks for BSX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does BSX compare to its competitors?

Compare BSX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize BSX's performance and positioning.

What is BSX's stock price target for 2026?

Our AI model provides price targets for BSX based on fundamental analysis: Bull case $58.01 (+30%), Base case $51.31 (+15%), Bear case $40.16 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about BSX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for BSX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is BSX's next earnings report?

BSX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

BSX - Boston Scientific Corp

NYSE * Healthcare * Medical Devices

$44.62

+$1.58 (+3.67%)

About Boston Scientific Corp

Boston Scientific Corp (BSX) common stock

Price Chart

Loading chart...

BSX Key Statistics

Market Cap

$71.81B

P/E Ratio

20.21

How BSX Compares to Peers

BSX has the lowest P/E ratio in Medical Devices, suggesting it may be the most undervalued

BSX is the smallest among peers, which may offer higher growth potential

P/E Rank

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
BSX(This stock)	$71.81B	20.2	0%	0.0%	-
ABTAbbott Laboratories	$154.15B	24.8	0%	0.0%	vs ABT
MDTMedtronic PLC	$100.08B	20.9	0%	0.0%	vs MDT
SYKStryker Corporation	$115.45B	34.9	0%	0.0%	vs SYK
ISRGIntuitive Surgical	$195.15B	80.0	0%	0.0%	vs ISRG

Data Updated: July 17, 2026 at 9:25 AM EDT

Ready to invest in BSX?

Commission-free trading available. Affiliate links.

BSX Lician Score

10% confidence

6.0/10

Good

BSX has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

9.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates BSXacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

BSX Financial Snowflake

5-axis analysis across key investment dimensions

5.8/10

Neutral

5.0

Value

Valuation vs. sector peers

9.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for BSX

Dashboard

Enter a ticker to analyze